PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1849767-0	1991	Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat.	Desipramine	52-63	gonadotropin releasing hormone receptor	Rattus norvegicus	13-27	
1387021-10	1992	Rats treated with DMI but not sertraline showed a virtually complete suppression of the growth hormone (GH) secretion elicited by clonidine in controls, while the secretion of corticosterone was augmented.	Desipramine	18-21	gonadotropin releasing hormone receptor	Rattus norvegicus	88-102	
1387021-10	1992	Rats treated with DMI but not sertraline showed a virtually complete suppression of the growth hormone (GH) secretion elicited by clonidine in controls, while the secretion of corticosterone was augmented.	Desipramine	18-21	gonadotropin releasing hormone receptor	Rattus norvegicus	104-106	
1849767-14	1991	DMI caused an activation through indirect mechanisms of alpha 2-adrenoceptors specifically involved in hypothalamic-pituitary regulation of GH release and also a distinct, independent and transient generalized activation of the pituitary-adrenal axis.	Desipramine	0-3	gonadotropin releasing hormone receptor	Rattus norvegicus	140-142	
12162636-8	2002	In animals challenged with clonidine, there was a significant age by treatment interaction effect for the prepubertal group pretreated with high doses of desipramine (less growth hormone secretion) but not for the peri- or postpubertal groups.	Desipramine	154-165	gonadotropin releasing hormone receptor	Rattus norvegicus	172-186	
1849767-2	1991	Acute intravenous administration of either clonidine (Clon) (50 micrograms kg-1) or desipramine (DMI) (5 mg kg-1) elicited a pulse of growth hormone (GH) and corticosterone secretion in conscious, unrestrained rats.	Desipramine	84-95	gonadotropin releasing hormone receptor	Rattus norvegicus	134-148	
1849767-2	1991	Acute intravenous administration of either clonidine (Clon) (50 micrograms kg-1) or desipramine (DMI) (5 mg kg-1) elicited a pulse of growth hormone (GH) and corticosterone secretion in conscious, unrestrained rats.	Desipramine	84-95	gonadotropin releasing hormone receptor	Rattus norvegicus	150-152	
1849767-2	1991	Acute intravenous administration of either clonidine (Clon) (50 micrograms kg-1) or desipramine (DMI) (5 mg kg-1) elicited a pulse of growth hormone (GH) and corticosterone secretion in conscious, unrestrained rats.	Desipramine	97-100	gonadotropin releasing hormone receptor	Rattus norvegicus	134-148	
1849767-2	1991	Acute intravenous administration of either clonidine (Clon) (50 micrograms kg-1) or desipramine (DMI) (5 mg kg-1) elicited a pulse of growth hormone (GH) and corticosterone secretion in conscious, unrestrained rats.	Desipramine	97-100	gonadotropin releasing hormone receptor	Rattus norvegicus	150-152	
1849767-4	1991	The responses to DMI were similar to those with Clon, except that the GH pulse following DMI was delayed and was not dose-dependent.	Desipramine	17-20	gonadotropin releasing hormone receptor	Rattus norvegicus	70-72	
1849767-4	1991	The responses to DMI were similar to those with Clon, except that the GH pulse following DMI was delayed and was not dose-dependent.	Desipramine	89-92	gonadotropin releasing hormone receptor	Rattus norvegicus	70-72	
1849767-6	1991	The GH response to DMI was inhibited by prior administration of idazoxan (1 mg kg-1) or yohimbine (0.5 mg kg-1), but not by atropine (10 micrograms kg-1), sulpiride (5 mg kg-1) or prazosin (1 mg kg-1).	Desipramine	19-22	gonadotropin releasing hormone receptor	Rattus norvegicus	4-6